DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -25.0% | 272 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | 0.0% | 272 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | 0.0% | 272 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 272 | +36.7% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 199 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 199 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 199 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -71.4% | 199 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | +75.0% | 199 | +86.0% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 107 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 107 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | -62.5% | 107 | -66.4% | 0.00% | – |
| Q3 2020 | $16,000 | +33.3% | 318 | +5.3% | 0.00% | – |
| Q2 2020 | $12,000 | 0.0% | 302 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -33.3% | 302 | +4.9% | 0.00% | – |
| Q4 2019 | $18,000 | +63.6% | 288 | -7.7% | 0.00% | – |
| Q3 2019 | $11,000 | +120.0% | 312 | +30.0% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 240 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | -14.3% | 240 | -27.3% | 0.00% | – |
| Q4 2018 | $7,000 | – | 330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |